Catamenial Epilepsy

When seizures occur in clusters during certain stages of the menstrual cycle (perimenstrual and periovulatory stages), it is defined as catamenial epilepsy. The prevalence varies between 10% and 70%. There are 3 patterns of catamenial epilepsy: perimenstrual (most common), periovulatory, and seizure...

Full description

Bibliographic Details
Main Authors: Rabia Gökçen GÖZÜBATIK ÇELİK, Çiğdem ÖZKARA
Format: Article
Language:English
Published: Galenos Yayinevi 2018-01-01
Series:Archives of Epilepsy
Subjects:
Online Access: http://archepilepsy.org/archives/archive-detail/article-preview/catamenial-epilepsy/54919
_version_ 1827888776445165568
author Rabia Gökçen GÖZÜBATIK ÇELİK
Çiğdem ÖZKARA
author_facet Rabia Gökçen GÖZÜBATIK ÇELİK
Çiğdem ÖZKARA
author_sort Rabia Gökçen GÖZÜBATIK ÇELİK
collection DOAJ
description When seizures occur in clusters during certain stages of the menstrual cycle (perimenstrual and periovulatory stages), it is defined as catamenial epilepsy. The prevalence varies between 10% and 70%. There are 3 patterns of catamenial epilepsy: perimenstrual (most common), periovulatory, and seizures in the insufficient luteal phase. In the pathophysiology of this occurrence, the neuroactive properties of the reproduction-associated steroid hormones (direct membrane-associated short-term effect and intracellular receptor/genomic-related longterm effect) and their cyclic changes in serum levels play a role in the susceptibility of the epileptogenic area to neuroactive steroids. Among steroid hormones, while progesterone and neurosteroids are known as anticonvulsants, estrogen, the best known proconvulsant, has been found in recent studies to also have anticonvulsant effects related to Neuropeptide Y. Hormonal (medroxyprogesterone acetate, clomiphene, triptorelin, leuprolide, progesterone, goserelin), non-hormonal (acetazolamide, clobazam, lamotrigine, levetiracetam), and neurosteroidbased therapies (ganaxolone) are used in the treatment of catamenial epilepsy. Seizure control and menstrual cycle maintenance, measurement of the blood level of antiepileptic drugs before and after menstruation and adjustment of the drug dosage as required, intermittent benzodiazepine administration, acetazolamide, or hormonal treatments such as oral contraceptives during menstruation are among the treatment strategies for catamenial epilepsy.
first_indexed 2024-03-12T20:39:36Z
format Article
id doaj.art-de1e5eb0c5fb49a38a5f2cb915f0c799
institution Directory Open Access Journal
issn 2792-0550
language English
last_indexed 2024-03-12T20:39:36Z
publishDate 2018-01-01
publisher Galenos Yayinevi
record_format Article
series Archives of Epilepsy
spelling doaj.art-de1e5eb0c5fb49a38a5f2cb915f0c7992023-08-01T11:13:34ZengGalenos YayineviArchives of Epilepsy2792-05502018-01-01241304010.14744/epilepsi.2018.2534913049054Catamenial EpilepsyRabia Gökçen GÖZÜBATIK ÇELİK0Çiğdem ÖZKARA1 Bakırköy Prof Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim Araştırma Hastanesi Nöroloji Bölümü, İstanbul Istanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Nöroloji Anabilim Dalı, İstanbul When seizures occur in clusters during certain stages of the menstrual cycle (perimenstrual and periovulatory stages), it is defined as catamenial epilepsy. The prevalence varies between 10% and 70%. There are 3 patterns of catamenial epilepsy: perimenstrual (most common), periovulatory, and seizures in the insufficient luteal phase. In the pathophysiology of this occurrence, the neuroactive properties of the reproduction-associated steroid hormones (direct membrane-associated short-term effect and intracellular receptor/genomic-related longterm effect) and their cyclic changes in serum levels play a role in the susceptibility of the epileptogenic area to neuroactive steroids. Among steroid hormones, while progesterone and neurosteroids are known as anticonvulsants, estrogen, the best known proconvulsant, has been found in recent studies to also have anticonvulsant effects related to Neuropeptide Y. Hormonal (medroxyprogesterone acetate, clomiphene, triptorelin, leuprolide, progesterone, goserelin), non-hormonal (acetazolamide, clobazam, lamotrigine, levetiracetam), and neurosteroidbased therapies (ganaxolone) are used in the treatment of catamenial epilepsy. Seizure control and menstrual cycle maintenance, measurement of the blood level of antiepileptic drugs before and after menstruation and adjustment of the drug dosage as required, intermittent benzodiazepine administration, acetazolamide, or hormonal treatments such as oral contraceptives during menstruation are among the treatment strategies for catamenial epilepsy. http://archepilepsy.org/archives/archive-detail/article-preview/catamenial-epilepsy/54919 antiepilepticsepilepsymenstrual cycleestrogen; pathophysiologyprogesteronereproductive hormone replacement therapy
spellingShingle Rabia Gökçen GÖZÜBATIK ÇELİK
Çiğdem ÖZKARA
Catamenial Epilepsy
Archives of Epilepsy
antiepileptics
epilepsy
menstrual cycle
estrogen; pathophysiology
progesterone
reproductive hormone replacement therapy
title Catamenial Epilepsy
title_full Catamenial Epilepsy
title_fullStr Catamenial Epilepsy
title_full_unstemmed Catamenial Epilepsy
title_short Catamenial Epilepsy
title_sort catamenial epilepsy
topic antiepileptics
epilepsy
menstrual cycle
estrogen; pathophysiology
progesterone
reproductive hormone replacement therapy
url http://archepilepsy.org/archives/archive-detail/article-preview/catamenial-epilepsy/54919
work_keys_str_mv AT rabiagokcengozubatikcelik catamenialepilepsy
AT cigdemozkara catamenialepilepsy